Clinical Trials Browser

Terminated × Lymphoma × Ipilimumab × Clear all

NCT02681302 2025-07-25

CPIT001

Phase 1/2 Terminated

46 enrolled 13 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT02675439 2021-12-30

Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas

Phase 1 Terminated

Lymphoma